Virios therapeutics, inc. and wex pharmaceuticals, inc. announce business combination to form dogwood therapeutics, inc. (nasdaq: “dwtx”)

Atlanta and vancouver, british columbia, oct. 07, 2024 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), and wex pharmaceuticals, inc. (“wex”), a wholly owned subsidiary of ck life sciences int'l., (holdings) inc. (“ckls”), today announced that virios has entered into a definitive share exchange agreement with sealbond limited, an indirect parent of wex, pursuant to which the companies will combine in an all-stock transaction (the “combination”).
VIRI Ratings Summary
VIRI Quant Ranking